WELCOME TO The HEALTHCARE REPORT
Newsletter | Member Login | Signup
Home > Companies > Beacon Healthcare Systems, Inc
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
Future of Healthcare
Veritas Capital | August 08, 2022
Veritas Capital a leading technology and government investor with deep healthcare expertise, announced that an affiliate of Veritas completed the combination of two complementary revenue cycle management businesses: Coronis Health and MiraMed Global Services. The combination creates a scaled RCM platform providing end-to-end technology-enabled solutions to a diverse set of healthcare providers across the U.S. The newly combined company benefits from meaningfully increased scale, end-to-end RC...
Future of Healthcare, Medical Devices
AA Medical | January 10, 2023
AA Medical, a sustainable solutions provider for new and old medical device equipment, recently partnered with Certified Endoscopy Products. Chicago-based Certified Endoscopy specializes in reprocessing endoscopic instruments. AA Medical and Certified Endoscopy will establish a prominent reprocessor company for endoscopy, orthopedic, and other surgical equipment. AA Medical is one of the largest and most respected aftermarket equipment companies in endoscopy, orthop...
Digital Healthcare
Biostrap | November 20, 2021
LCA Vantage Healthcare Corporation ("LCAV"), an innovative technology company, partners with Biostrap USA LLC ("Biostrap"), a digital health solutions company, to provide the world's first Electronic Health Record (EHR) and overall SMART Tract® Health system that integrates continuous biometric monitoring to improve patient care and overcome administrative and technological challenges. Advancing health care into the next century, LCAV created a full-stack...
Anumana | December 16, 2022
Anumana, Inc., an AI-driven health technology company and portfolio company of nference, has entered into a multi-year agreement with Pfizer, Inc. for Anumana to develop an artificial intelligence electrocardiogram algorithm designed to enable the early suspicion of cardiac amyloidosis. Anumana will conduct a clinical validation trial and pursue De Novo classification for the algorithm as a Software-as-a-Medical-Device and aims to gain regulatory approval for the algorithm as an SaMD for the ...
Article
Whitepaper
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Welcome back!
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE